Enhancement of the binding affinity of methylene blue to site I in human serum albumin by cupric and ferric ions.

Article Details

Citation

Copy to clipboard

He LL, Wang YX, Wu XX, Liu XP, Wang X, Liu B, Wang X

Enhancement of the binding affinity of methylene blue to site I in human serum albumin by cupric and ferric ions.

Luminescence. 2015 Dec;30(8):1380-8. doi: 10.1002/bio.2910. Epub 2015 Mar 31.

PubMed ID

25833007 [ View in PubMed

]

Abstract

In this work, the binding characteristics of methylene blue (MB) to human serum albumin (HSA) and the influence of Cu(2+) and Fe(3+) on the binding affinity of MB to HSA were investigated using fluorescence, absorption, circular dichroism (CD) spectroscopy and molecular modelling. The results of competitive binding experiments using the site probes ketoprofen and ibuprofen as specific markers suggested that MB was located in site I within sub-domain IIA of HSA. The molecular modelling results agreed with the results of competitive site marker experiments and the results of CD spectra indicated that the interaction between MB and HSA caused the conformational changes in HSA. The binding affinity of MB to HSA was enhanced but to a different extent in the presence of Cu(2+) and Fe(3+), respectively, which indicated that the influence of different metal ions varied. Enhancement of the binding affinity of MB to HSA in the presence of Cu(2+) is due to the formation of Cu(2+)-HSA complex leading to the conformational changes in HSA, whereas in the presence of Fe(3+), enhancement of the binding affinity is due to the greater stability of the Fe(3+)-HSA-MB complex compared with the MB-HSA complex.

DrugBank Data that Cites this Article

Drug Carriers

Drug	Carrier	Kind	Organism	Pharmacological Action	Actions
Methylene blue	Serum albumin	Protein	Humans	Unknown	Binder	Details